Biotechnology
The Biotechnology industry has a total of 601 stocks, with a combined market cap of $1.1 trillion and total revenue of $106 billion.
Market Cap
1.1T
Revenue
106B
Profits
-41.8B
PE Ratio
n/a
Profit Margin
-39.43%
Dividend Yield
0.04%
601 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 116.04B | -1.32% | 283,843 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.99B | 0.67% | 130,868 | 14.34B |
| 3 | ARGX | argenx SE | 51.64B | -0.27% | 39,803 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.79B | 0.28% | 289,769 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 38.33B | -2.01% | 26,275 | 4.97B |
| 6 | INSM | Insmed Incorporated | 31.18B | -1.58% | 281,702 | 447.02M |
| 7 | BNTX | BioNTech SE | 27.04B | -1.09% | 109,490 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 25.87B | 1.38% | 1,211,173 | 2.35B |
| 9 | INCY | Incyte Corporation | 19.29B | -1.79% | 349,842 | 5.14B |
| 10 | GMAB | Genmab A/S | 19.02B | -3.01% | 376,550 | 3.85B |
| 11 | ROIV | Roivant Sciences Ltd. | 18.97B | -3.09% | 882,122 | 13.31M |
| 12 | RVMD | Revolution Medicines, Inc. | 18.17B | -2.09% | 445,445 | - |
| 13 | MRNA | Moderna, Inc. | 14.66B | -10.68% | 5,864,488 | 2.23B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 13.70B | -1.93% | 301,947 | 353.78M |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 13.39B | -1.90% | 136,290 | 966.96M |
| 16 | ASND | Ascendis Pharma A/S | 13.30B | -3.35% | 163,751 | 758.59M |
| 17 | BMRN | BioMarin Pharmaceutical Inc. | 11.57B | 0.92% | 333,453 | 3.09B |
| 18 | SMMT | Summit Therapeutics Inc. | 11.44B | -2.75% | 228,546 | - |
| 19 | EXEL | Exelixis, Inc. | 11.00B | -1.47% | 814,407 | 2.32B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.98B | -0.05% | 420,607 | 20.87M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.64B | -2.15% | 47,658 | 740.64M |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 9.94B | -1.26% | 41,232 | 4.16B |
| 23 | TECH | Bio-Techne Corporation | 9.89B | -2.46% | 308,650 | 1.22B |
| 24 | HALO | Halozyme Therapeutics, Inc. | 9.43B | -0.04% | 258,811 | 1.24B |
| 25 | ABVX | ABIVAX Société Anonyme | 9.35B | -2.07% | 66,516 | 6.23M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 9.20B | -0.95% | 55,259 | 561.26M |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.56B | -2.80% | 430,368 | 1.09B |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 8.55B | -3.83% | 131,305 | 7.46M |
| 29 | CYTK | Cytokinetics, Incorporated | 7.87B | -0.79% | 328,233 | 87.21M |
| 30 | NUVL | Nuvalent, Inc. | 7.73B | -2.43% | 66,296 | - |
| 31 | KRYS | Krystal Biotech, Inc. | 7.73B | -1.52% | 34,803 | 373.16M |
| 32 | PCVX | Vaxcyte, Inc. | 7.64B | -3.22% | 145,788 | - |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.58B | -4.19% | 105,881 | 174.33M |
| 34 | BLTE | Belite Bio, Inc | 6.31B | -4.90% | 50,487 | - |
| 35 | IBRX | ImmunityBio, Inc. | 6.25B | -3.20% | 6,096,423 | 82.56M |
| 36 | KYMR | Kymera Therapeutics, Inc. | 6.19B | -2.67% | 88,129 | 43.74M |
| 37 | CAI | Caris Life Sciences, Inc. | 6.01B | -3.88% | 261,168 | 649.06M |
| 38 | MIRM | Mirum Pharmaceuticals, Inc. | 5.94B | -1.64% | 58,581 | 471.79M |
| 39 | PTCT | PTC Therapeutics, Inc. | 5.67B | -2.18% | 84,696 | 1.78B |
| 40 | COGT | Cogent Biosciences, Inc. | 5.54B | -3.57% | 122,883 | - |
| 41 | IMVT | Immunovant, Inc. | 5.29B | -2.53% | 190,243 | - |
| 42 | GPCR | Structure Therapeutics Inc. | 5.25B | -3.25% | 93,877 | - |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.13B | -2.26% | 46,921 | 209.22M |
| 44 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.81B | -1.37% | 98,747 | 1.54M |
| 45 | SRRK | Scholar Rock Holding Corporation | 4.76B | -2.02% | 102,849 | - |
| 46 | CELC | Celcuity Inc. | 4.54B | -5.83% | 446,420 | - |
| 47 | FOLD | Amicus Therapeutics, Inc. | 4.49B | 0.03% | 822,696 | 598.70M |
| 48 | CRSP | CRISPR Therapeutics AG | 4.45B | -4.46% | 371,913 | 38.34M |
| 49 | APGE | Apogee Therapeutics, Inc. | 4.27B | -3.45% | 93,093 | - |
| 50 | CGON | CG Oncology, Inc. | 4.20B | -1.93% | 69,993 | 2.17M |
| 51 | CORT | Corcept Therapeutics Incorporated | 4.19B | -2.78% | 124,423 | 741.17M |
| 52 | TGTX | TG Therapeutics, Inc. | 4.13B | -3.05% | 176,918 | 531.90M |
| 53 | TERN | Terns Pharmaceuticals, Inc. | 4.08B | -1.70% | 410,949 | - |
| 54 | ACLX | Arcellx, Inc. | 3.93B | 1.17% | 125,287 | 35.90M |
| 55 | NAMS | NewAmsterdam Pharma Company N.V. | 3.82B | -3.38% | 65,745 | 35.24M |
| 56 | ADMA | ADMA Biologics, Inc. | 3.79B | -2.06% | 231,459 | 488.56M |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 3.77B | -1.76% | 168,093 | 1.05B |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 3.59B | -2.42% | 42,823 | 251.23M |
| 59 | ERAS | Erasca, Inc. | 3.57B | -3.51% | 840,610 | - |
| 60 | LQDA | Liquidia Corporation | 3.39B | -3.80% | 324,561 | 69.22M |
| 61 | LEGN | Legend Biotech Corporation | 3.36B | 1.56% | 425,112 | 909.05M |
| 62 | CNTA | Centessa Pharmaceuticals plc | 3.33B | -3.14% | 49,367 | 15.00M |
| 63 | ALMS | Alumis Inc. | 3.26B | -1.58% | 166,590 | 22.12M |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.23B | -2.02% | 201,205 | 7.50M |
| 65 | ARQT | Arcutis Biotherapeutics, Inc. | 3.18B | -3.42% | 137,350 | 317.93M |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.15B | -4.10% | 76,417 | - |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.09B | -5.01% | 1,166,158 | - |
| 68 | VERA | Vera Therapeutics, Inc. | 3.04B | -2.72% | 134,001 | - |
| 69 | DNLI | Denali Therapeutics Inc. | 3.02B | -2.27% | 393,817 | - |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.93B | -1.94% | 300,814 | 578.20M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 2.85B | -0.77% | 210,329 | 70.79M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 2.82B | -3.40% | 227,241 | 214.83M |
| 73 | APLS | Apellis Pharmaceuticals, Inc. | 2.80B | -2.06% | 157,712 | 1.02B |
| 74 | IRON | Disc Medicine, Inc. | 2.74B | -3.04% | 25,217 | - |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 2.70B | -3.34% | 57,273 | 366.10M |
| 76 | DYN | Dyne Therapeutics, Inc. | 2.70B | -4.32% | 220,464 | - |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.61B | -3.69% | 150,194 | 435.83M |
| 78 | IMNM | Immunome, Inc. | 2.58B | -6.18% | 206,744 | 9.68M |
| 79 | SYRE | Spyre Therapeutics, Inc. | 2.53B | -2.77% | 73,775 | - |
| 80 | BEAM | Beam Therapeutics Inc. | 2.53B | -5.01% | 436,220 | 55.70M |
| 81 | RCUS | Arcus Biosciences, Inc. | 2.52B | -2.09% | 60,988 | 240.00M |
| 82 | WVE | Wave Life Sciences Ltd. | 2.42B | -2.50% | 321,304 | 109.23M |
| 83 | MESO | Mesoblast Limited | 2.35B | -0.11% | 62,380 | 17.20M |
| 84 | TLX | Telix Pharmaceuticals Limited | 2.34B | -4.70% | 82,743 | 664.23M |
| 85 | MLYS | Mineralys Therapeutics, Inc. | 2.33B | -5.31% | 206,180 | - |
| 86 | ADPT | Adaptive Biotechnologies Corporation | 2.33B | -3.32% | 259,932 | 276.98M |
| 87 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | -2.44% | 204,547 | 630.60M |
| 88 | AAPG | Ascentage Pharma Group International | 2.24B | 2.50% | 304 | 54.52M |
| 89 | GLPG | Galapagos NV | 2.23B | -0.32% | 23,489 | 336.64M |
| 90 | MAZE | Maze Therapeutics, Inc. | 2.20B | -5.69% | 112,972 | 2.50M |
| 91 | DNTH | Dianthus Therapeutics, Inc. | 2.16B | -1.79% | 43,845 | 3.08M |
| 92 | SLNO | Soleno Therapeutics, Inc. | 2.13B | -2.02% | 143,606 | 98.68M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 2.12B | -2.98% | 87,888 | 825.94M |
| 94 | ZLAB | Zai Lab Limited | 2.08B | -4.91% | 164,624 | 441.63M |
| 95 | RXRX | Recursion Pharmaceuticals, Inc. | 1.92B | -4.42% | 8,630,909 | 43.69M |
| 96 | OCUL | Ocular Therapeutix, Inc. | 1.91B | -2.77% | 846,770 | 51.95M |
| 97 | NUVB | Nuvation Bio Inc. | 1.90B | -2.80% | 602,927 | 26.75M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.88B | -1.92% | 113,362 | 265.81M |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -3.82% | 329,689 | 2.41B |
| 100 | SNDX | Syndax Pharmaceuticals, Inc. | 1.83B | -1.22% | 268,859 | 111.30M |
| 101 | OLMA | Olema Pharmaceuticals, Inc. | 1.79B | -2.70% | 281,712 | - |
| 102 | RAPT | RAPT Therapeutics, Inc. | 1.79B | 0.05% | 4,302,510 | - |
| 103 | STOK | Stoke Therapeutics, Inc. | 1.78B | -3.91% | 69,977 | 205.63M |
| 104 | MNKD | MannKind Corporation | 1.75B | -1.97% | 402,974 | 313.79M |
| 105 | VCEL | Vericel Corporation | 1.74B | -3.06% | 31,111 | 258.72M |
| 106 | ARDX | Ardelyx, Inc. | 1.74B | -2.12% | 493,677 | 398.23M |
| 107 | PHVS | Pharvaris N.V. | 1.73B | -3.02% | 11,843 | - |
| 108 | ZYME | Zymeworks Inc. | 1.67B | -1.98% | 72,373 | 134.48M |
| 109 | DFTX | Definium Therapeutics, Inc. | 1.65B | -3.34% | 204,340 | - |
| 110 | IMCR | Immunocore Holdings plc | 1.65B | -0.67% | 29,221 | 379.59M |
| 111 | TNGX | Tango Therapeutics, Inc. | 1.65B | -3.70% | 498,667 | 66.50M |
| 112 | NRIX | Nurix Therapeutics, Inc. | 1.65B | -2.74% | 210,553 | 83.98M |
| 113 | MBX | MBX Biosciences, Inc. | 1.64B | -7.48% | 111,273 | - |
| 114 | INVA | Innoviva, Inc. | 1.63B | 0.05% | 41,345 | 388.52M |
| 115 | OCS | Oculis Holding AG | 1.63B | -2.22% | 72,672 | 992.00K |
| 116 | SION | Sionna Therapeutics, Inc. | 1.63B | -4.12% | 36,887 | - |
| 117 | CLDX | Celldex Therapeutics, Inc. | 1.60B | -2.23% | 41,799 | 2.60M |
| 118 | ELVN | Enliven Therapeutics, Inc. | 1.59B | -3.80% | 89,530 | - |
| 119 | PGEN | Precigen, Inc. | 1.58B | -4.29% | 453,468 | 6.31M |
| 120 | CRVS | Corvus Pharmaceuticals, Inc. | 1.58B | -3.93% | 443,144 | - |
| 121 | TYRA | Tyra Biosciences, Inc. | 1.57B | -6.59% | 278,708 | - |
| 122 | ORKA | Oruka Therapeutics, Inc. | 1.55B | -2.34% | 22,076 | - |
| 123 | BHVN | Biohaven Ltd. | 1.53B | -5.25% | 352,175 | - |
| 124 | AGIO | Agios Pharmaceuticals, Inc. | 1.53B | -3.46% | 243,018 | 44.79M |
| 125 | QURE | uniQure N.V. | 1.50B | -2.63% | 317,136 | 15.75M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -3.40% | 117,757 | 181.54M |
| 127 | RLAY | Relay Therapeutics, Inc. | 1.48B | -4.89% | 354,540 | 8.36M |
| 128 | MANE | Veradermics, Incorporated | 1.46B | -3.58% | 25,431 | - |
| 129 | DBVT | DBV Technologies S.A. | 1.42B | -7.23% | 71,276 | 5.50M |
| 130 | NVAX | Novavax, Inc. | 1.42B | -0.34% | 1,135,967 | 1.06B |
| 131 | TRVI | Trevi Therapeutics, Inc. | 1.37B | -4.98% | 134,153 | - |
| 132 | KOD | Kodiak Sciences Inc. | 1.37B | -5.32% | 63,401 | - |
| 133 | ATAI | AtaiBeckley Inc. | 1.37B | -2.34% | 587,046 | 3.02M |
| 134 | ANAB | AnaptysBio, Inc. | 1.33B | -4.14% | 91,467 | 169.47M |
| 135 | NTLA | Intellia Therapeutics, Inc. | 1.33B | -3.82% | 1,058,002 | 57.53M |
| 136 | IMTX | Immatics N.V. | 1.31B | -1.61% | 60,626 | 99.45M |
| 137 | NKTR | Nektar Therapeutics | 1.31B | 14.56% | 1,727,700 | 62.60M |
| 138 | SVRA | Savara Inc. | 1.27B | -2.09% | 230,178 | - |
| 139 | RAPP | Rapport Therapeutics, Inc. | 1.27B | -5.66% | 37,450 | - |
| 140 | CAPR | Capricor Therapeutics, Inc. | 1.24B | -2.64% | 70,258 | 11.13M |
| 141 | IVA | Inventiva S.A. | 1.22B | -3.90% | 252,992 | 19.93M |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.21B | -1.90% | 407,108 | 6.31M |
| 143 | NBTX | Nanobiotix S.A. | 1.20B | -9.04% | 21,768 | 11.93M |
| 144 | SEPN | Septerna, Inc. | 1.16B | -3.18% | 22,468 | 22.05M |
| 145 | XERS | Xeris Biopharma Holdings, Inc. | 1.16B | -3.46% | 196,341 | 266.14M |
| 146 | FTRE | Fortrea Holdings Inc. | 1.15B | -9.00% | 566,467 | 2.76B |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.14B | -6.04% | 35,628 | 1.40M |
| 148 | ZBIO | Zenas BioPharma, Inc. | 1.13B | -1.72% | 191,631 | 15.00M |
| 149 | CMPX | Compass Therapeutics, Inc. | 1.13B | -3.79% | 398,216 | 850.00K |
| 150 | PHAR | Pharming Group N.V. | 1.11B | -2.84% | 6,554 | 362.27M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.11B | -0.19% | 130,517 | - |
| 152 | DAWN | Day One Biopharmaceuticals, Inc. | 1.11B | -5.12% | 215,168 | 133.67M |
| 153 | EYPT | EyePoint, Inc. | 1.07B | -5.54% | 173,798 | 42.34M |
| 154 | VIR | Vir Biotechnology, Inc. | 1.02B | -2.53% | 322,911 | 16.86M |
| 155 | ORIC | ORIC Pharmaceuticals, Inc. | 1.01B | -1.75% | 134,073 | - |
| 156 | GERN | Geron Corporation | 1.01B | -2.78% | 1,975,571 | 183.40M |
| 157 | VTYX | Ventyx Biosciences, Inc. | 1.00B | -0.11% | 382,951 | - |
| 158 | SANA | Sana Biotechnology, Inc. | 997.54M | -2.98% | 455,027 | - |
| 159 | IOVA | Iovance Biotherapeutics, Inc. | 996.39M | -3.46% | 1,843,652 | 250.43M |
| 160 | URGN | UroGen Pharma Ltd. | 985.33M | -2.86% | 183,549 | 96.52M |
| 161 | PHAT | Phathom Pharmaceuticals, Inc. | 973.99M | -2.96% | 70,499 | 147.19M |
| 162 | TBPH | Theravance Biopharma, Inc. | 962.78M | -2.06% | 36,914 | 80.33M |
| 163 | PVLA | Palvella Therapeutics, Inc. | 929.16M | -3.10% | 39,775 | - |
| 164 | GHRS | GH Research PLC | 926.10M | -2.61% | 36,220 | - |
| 165 | SGP | SpyGlass Pharma, Inc. | 920.23M | -0.75% | 5,418 | - |
| 166 | ABCL | AbCellera Biologics Inc. | 918.96M | -2.85% | 1,854,307 | 35.33M |
| 167 | AKTS | Aktis Oncology, Inc. | 917.56M | -1.85% | 43,866 | 5.56M |
| 168 | SPRY | ARS Pharmaceuticals, Inc. | 915.34M | -6.65% | 291,001 | 142.77M |
| 169 | CTMX | CytomX Therapeutics, Inc. | 898.01M | -4.16% | 420,829 | 113.63M |
| 170 | VALN | Valneva SE | 861.84M | -2.95% | 1,750 | 211.09M |
| 171 | XNCR | Xencor, Inc. | 858.35M | -2.83% | 75,424 | 150.13M |
| 172 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 843.88M | -2.68% | 34,607 | - |
| 173 | AVBP | ArriVent BioPharma, Inc. | 842.14M | -3.23% | 71,746 | - |
| 174 | ARVN | Arvinas, Inc. | 836.84M | -3.05% | 138,593 | 312.30M |
| 175 | BCAX | Bicara Therapeutics Inc. | 795.98M | -2.94% | 31,883 | - |
| 176 | ANNX | Annexon, Inc. | 790.00M | -5.53% | 325,210 | - |
| 177 | EVMN | Evommune, Inc. | 787.47M | -13.95% | 479,087 | 13.00M |
| 178 | UPB | Upstream Bio, Inc. | 784.64M | -47.79% | 3,477,548 | 2.80M |
| 179 | OMER | Omeros Corporation | 783.45M | -1.07% | 138,334 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 782.76M | -2.16% | 389,029 | 14.61M |
| 181 | MRVI | Maravai LifeSciences Holdings, Inc. | 781.18M | -2.08% | 303,059 | 192.44M |
| 182 | JANX | Janux Therapeutics, Inc. | 777.11M | -1.60% | 159,636 | 10.00M |
| 183 | YDES | YD Bio Limited | 775.63M | -1.52% | 4,491 | 510.36K |
| 184 | MPLT | MapLight Therapeutics, Inc. | 770.27M | -1.34% | 67,442 | - |
| 185 | MDXG | MiMedx Group, Inc. | 766.43M | 0.10% | 148,856 | 393.44M |
| 186 | AGMB | AgomAb Therapeutics NV | 755.42M | -0.32% | 96,326 | - |
| 187 | KALV | KalVista Pharmaceuticals, Inc. | 753.65M | -0.67% | 235,787 | 1.43M |
| 188 | DRUG | Bright Minds Biosciences Inc. | 740.63M | -0.17% | 10,449 | - |
| 189 | EIKN | Eikon Therapeutics, Inc. | 730.95M | -0.37% | 66,097 | - |
| 190 | GYRE | Gyre Therapeutics, Inc. | 705.31M | -2.63% | 12,464 | 107.27M |
| 191 | CGEM | Cullinan Therapeutics, Inc. | 688.83M | -4.35% | 307,891 | - |
| 192 | FULC | Fulcrum Therapeutics, Inc. | 679.49M | -0.39% | 118,165 | 80.00M |
| 193 | KURA | Kura Oncology, Inc. | 656.98M | -3.70% | 154,638 | 104.03M |
| 194 | JBIO | Jade Biosciences, Inc. | 639.46M | -4.20% | 20,163 | - |
| 195 | ENGN | enGene Holdings Inc. | 638.36M | - | 24,204 | - |
| 196 | REPL | Replimune Group, Inc. | 625.07M | -2.95% | 101,822 | - |
| 197 | SLS | SELLAS Life Sciences Group, Inc. | 611.31M | -4.52% | 1,423,170 | - |
| 198 | RIGL | Rigel Pharmaceuticals, Inc. | 610.97M | -2.77% | 52,963 | 282.08M |
| 199 | LBRX | LB Pharmaceuticals Inc | 609.96M | -0.45% | 9,072 | - |
| 200 | DRTS | Alpha Tau Medical Ltd. | 602.82M | -3.94% | 93,213 | - |
| 201 | CRMD | CorMedix Inc. | 590.92M | -2.47% | 282,648 | 214.30M |
| 202 | MGTX | MeiraGTx Holdings plc | 587.58M | -2.93% | 70,822 | 27.42M |
| 203 | PRME | Prime Medicine, Inc. | 586.00M | -3.22% | 544,055 | 5.98M |
| 204 | DSGN | Design Therapeutics, Inc. | 581.03M | -0.29% | 70,479 | - |
| 205 | PROK | ProKidney Corp. | 577.60M | -4.48% | 158,327 | 744.00K |
| 206 | ALT | Altimmune, Inc. | 576.06M | -1.08% | 392,944 | 20.00K |
| 207 | LXRX | Lexicon Pharmaceuticals, Inc. | 555.21M | -0.76% | 662,488 | 70.86M |
| 208 | CTNM | Contineum Therapeutics, Inc. | 553.42M | -3.81% | 39,003 | - |
| 209 | VOR | Vor Biopharma Inc. | 540.17M | -6.34% | 215,199 | - |
| 210 | GOSS | Gossamer Bio, Inc. | 528.88M | -1.93% | 1,489,705 | 44.05M |
| 211 | FBRX | Forte Biosciences, Inc. | 520.77M | -0.93% | 19,402 | - |
| 212 | TENX | Tenax Therapeutics, Inc. | 516.66M | -0.43% | 37,898 | - |
| 213 | DNA | Ginkgo Bioworks Holdings, Inc. | 512.58M | -2.29% | 270,558 | 180.61M |
| 214 | KROS | Keros Therapeutics, Inc. | 497.21M | -4.84% | 65,190 | 246.72M |
| 215 | SLDB | Solid Biosciences Inc. | 491.61M | -8.95% | 242,304 | - |
| 216 | LXEO | Lexeo Therapeutics, Inc. | 489.74M | -4.69% | 127,762 | - |
| 217 | ANRO | Alto Neuroscience, Inc. | 487.43M | -5.77% | 49,205 | - |
| 218 | NMRA | Neumora Therapeutics, Inc. | 478.38M | -5.85% | 444,033 | - |
| 219 | LYEL | Lyell Immunopharma, Inc. | 477.67M | -5.17% | 16,535 | 41.00K |
| 220 | VSTM | Verastem, Inc. | 470.81M | -2.87% | 199,694 | 13.38M |
| 221 | PRTA | Prothena Corporation plc | 470.47M | -2.46% | 93,952 | 11.79M |
| 222 | ZVRA | Zevra Therapeutics, Inc. | 468.40M | -3.37% | 203,458 | 84.39M |
| 223 | ADCT | ADC Therapeutics SA | 455.87M | -5.64% | 53,645 | 75.21M |
| 224 | FDMT | 4D Molecular Therapeutics, Inc. | 454.99M | -1.98% | 138,188 | 120.00K |
| 225 | OCGN | Ocugen, Inc. | 447.57M | -3.87% | 819,908 | 5.37M |
| 226 | ZURA | Zura Bio Limited | 446.14M | -5.98% | 53,489 | - |
| 227 | IVVD | Invivyd, Inc. | 434.26M | -5.52% | 684,418 | 50.04M |
| 228 | VTVT | vTv Therapeutics Inc. | 433.57M | -0.57% | 4,941 | 17.00K |
| 229 | DMAC | DiaMedica Therapeutics Inc. | 433.45M | -3.23% | 13,815 | - |
| 230 | EPRX | Eupraxia Pharmaceuticals Inc. | 433.26M | -3.15% | 15,364 | - |
| 231 | RGNX | REGENXBIO Inc. | 432.83M | -3.39% | 327,648 | 161.32M |
| 232 | KYTX | Kyverna Therapeutics, Inc. | 428.47M | -4.46% | 116,161 | - |
| 233 | PRTC | PureTech Health plc | 427.48M | - | 2 | 6.39M |
| 234 | VNDA | Vanda Pharmaceuticals Inc. | 424.90M | -3.10% | 164,331 | 212.07M |
| 235 | LCTX | Lineage Cell Therapeutics, Inc. | 421.65M | -5.43% | 383,971 | 10.82M |
| 236 | ASMB | Assembly Biosciences, Inc. | 413.38M | -4.89% | 13,838 | 37.19M |
| 237 | LENZ | LENZ Therapeutics, Inc. | 411.93M | -3.62% | 210,812 | 17.50M |
| 238 | ENTA | Enanta Pharmaceuticals, Inc. | 409.45M | -0.14% | 49,228 | 66.98M |
| 239 | IMMP | Immutep Limited | 406.41M | -2.16% | 27,566 | 3.31M |
| 240 | NAGE | Niagen Bioscience, Inc. | 396.44M | -3.32% | 209,121 | 124.71M |
| 241 | NBP | NovaBridge Biosciences | 394.87M | 0.15% | 61,624 | - |
| 242 | BNTC | Benitec Biopharma Inc. | 384.68M | -4.02% | 11,047 | - |
| 243 | ABSI | Absci Corporation | 383.45M | -3.41% | 668,050 | 2.82M |
| 244 | MNPR | Monopar Therapeutics Inc. | 381.44M | 0.02% | 85,635 | - |
| 245 | TRDA | Entrada Therapeutics, Inc. | 380.49M | -1.94% | 23,747 | 61.52M |
| 246 | PEPG | PepGen Inc. | 378.80M | - | 182,006 | - |
| 247 | BCYC | Bicycle Therapeutics plc | 375.63M | -3.82% | 32,437 | 28.34M |
| 248 | GLSI | Greenwich LifeSciences, Inc. | 373.24M | -3.75% | 29,052 | - |
| 249 | AUTL | Autolus Therapeutics plc | 368.61M | -3.15% | 226,087 | 51.13M |
| 250 | ACRS | Aclaris Therapeutics, Inc. | 368.37M | -6.85% | 258,786 | 15.74M |
| 251 | ALLO | Allogene Therapeutics, Inc. | 367.43M | -3.25% | 651,125 | 22.00K |
| 252 | ANL | Adlai Nortye Ltd. | 357.75M | -0.46% | 9,825 | -1.35M |
| 253 | IMMX | Immix Biopharma, Inc. | 355.69M | 0.30% | 160,044 | - |
| 254 | TECX | Tectonic Therapeutic, Inc. | 355.61M | -9.74% | 266,739 | - |
| 255 | AVXL | Anavex Life Sciences Corp. | 351.23M | -4.29% | 357,283 | - |
| 256 | AURA | Aura Biosciences, Inc. | 346.09M | -3.20% | 59,295 | - |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 344.69M | -1.70% | 297,088 | - |
| 258 | TARA | Protara Therapeutics, Inc. | 335.99M | -2.64% | 63,108 | - |
| 259 | PBYI | Puma Biotechnology, Inc. | 327.04M | -1.82% | 76,866 | 212.00M |
| 260 | ALDX | Aldeyra Therapeutics, Inc. | 325.18M | -1.37% | 333,231 | - |
| 261 | IPSC | Century Therapeutics, Inc. | 325.16M | -6.22% | 203,425 | 113.34M |
| 262 | AVIR | Atea Pharmaceuticals, Inc. | 324.23M | -0.24% | 58,715 | - |
| 263 | IMRX | Immuneering Corporation | 319.62M | -1.39% | 127,497 | - |
| 264 | HELP | Cybin Inc. | 306.41M | -4.21% | 201,867 | - |
| 265 | FHTX | Foghorn Therapeutics Inc. | 302.89M | -5.13% | 20,587 | 24.52M |
| 266 | XFOR | X4 Pharmaceuticals, Inc. | 301.66M | -7.01% | 64,245 | 33.98M |
| 267 | CADL | Candel Therapeutics, Inc. | 298.10M | -5.73% | 167,736 | - |
| 268 | ACIU | AC Immune SA | 293.86M | -2.94% | 57,134 | 5.48M |
| 269 | CLLS | Cellectis S.A. | 290.49M | -6.17% | 2,060 | 82.55M |
| 270 | ARMP | Armata Pharmaceuticals, Inc. | 287.61M | -2.83% | 3,593 | 5.05M |
| 271 | XOMA | XOMA Royalty Corporation | 286.30M | 1.00% | 42,159 | 47.11M |
| 272 | RZLT | Rezolute, Inc. | 282.36M | -0.81% | 376,254 | - |
| 273 | RLMD | Relmada Therapeutics, Inc. | 280.87M | -4.73% | 133,656 | - |
| 274 | LRMR | Larimar Therapeutics, Inc. | 280.74M | -1.50% | 204,782 | - |
| 275 | ABEO | Abeona Therapeutics Inc. | 270.41M | -2.54% | 261,662 | 400.00K |
| 276 | ENLV | Enlivex Therapeutics Ltd. | 269.43M | -1.30% | 30,126 | - |
| 277 | AARD | Aardvark Therapeutics, Inc. | 263.46M | -4.04% | 24,195 | - |
| 278 | NERV | Minerva Neurosciences, Inc. | 262.24M | -3.96% | 32,901 | - |
| 279 | FENC | Fennec Pharmaceuticals Inc. | 260.93M | -1.93% | 8,400 | 38.79M |
| 280 | STRO | Sutro Biopharma, Inc. | 260.16M | 1.50% | 22,750 | 105.65M |
| 281 | PALI | Palisade Bio, Inc. | 257.78M | - | 806,790 | - |
| 282 | NAUT | Nautilus Biotechnology, Inc. | 255.14M | -4.72% | 53,057 | - |
| 283 | NGNE | Neurogene Inc. | 253.88M | -3.59% | 17,516 | 925.00K |
| 284 | AVTX | Avalo Therapeutics, Inc. | 251.77M | -6.91% | 54,939 | 192.00K |
| 285 | CLYM | Climb Bio, Inc. | 249.23M | -5.09% | 128,343 | - |
| 286 | OABI | OmniAb, Inc. | 246.16M | -1.16% | 53,952 | 21.09M |
| 287 | STTK | Shattuck Labs, Inc. | 244.26M | -4.93% | 65,235 | 1.00M |
| 288 | CHRS | Coherus Oncology, Inc. | 242.35M | -4.98% | 263,083 | 277.73M |
| 289 | CABA | Cabaletta Bio, Inc. | 241.63M | -3.46% | 559,771 | - |
| 290 | IRD | Opus Genetics, Inc. | 234.48M | -2.58% | 375,221 | 14.63M |
| 291 | PLX | Protalix BioTherapeutics, Inc. | 225.98M | 4.07% | 512,783 | 61.84M |
| 292 | HRTX | Heron Therapeutics, Inc. | 225.54M | -3.15% | 148,844 | 155.10M |
| 293 | CAMP | Camp4 Therapeutics Corporation | 223.09M | -5.29% | 19,861 | 3.80M |
| 294 | IKT | Inhibikase Therapeutics, Inc. | 222.96M | 1.87% | 248,558 | 1.00 |
| 295 | MDWD | MediWound Ltd. | 222.84M | -1.19% | 3,840 | 20.93M |
| 296 | OBIO | Orchestra BioMed Holdings, Inc. | 221.62M | -5.88% | 38,643 | 2.82M |
| 297 | ACHV | Achieve Life Sciences, Inc. | 220.65M | -4.93% | 190,374 | - |
| 298 | NVCT | Nuvectis Pharma, Inc. | 218.24M | -2.52% | 27,482 | - |
| 299 | CNTX | Context Therapeutics Inc. | 211.32M | -2.54% | 459,803 | - |
| 300 | NTHI | NeOnc Technologies Holdings, Inc. | 209.43M | 0.32% | 9,270 | 59.99K |
| 301 | VYGR | Voyager Therapeutics, Inc. | 205.72M | - | 77,955 | 31.32M |
| 302 | ARCT | Arcturus Therapeutics Holdings Inc. | 205.72M | -4.36% | 109,933 | 97.60M |
| 303 | SLN | Silence Therapeutics plc | 204.76M | -3.24% | 26,429 | 25.83M |
| 304 | ALEC | Alector, Inc. | 204.66M | -3.85% | 163,920 | 69.05M |
| 305 | SRZN | Surrozen, Inc. | 203.66M | 4.05% | 43,892 | 3.60M |
| 306 | OVID | Ovid Therapeutics Inc. | 200.48M | -6.10% | 280,617 | 6.61M |
| 307 | HUMA | Humacyte, Inc. | 197.82M | -2.38% | 2,060,966 | 1.57M |
| 308 | TNXP | Tonix Pharmaceuticals Holding Corp. | 194.34M | -4.53% | 99,877 | 10.30M |
| 309 | SABS | SAB Biotherapeutics, Inc. | 193.28M | -2.87% | 46,494 | 114.70K |
| 310 | PLYX | Polaryx Therapeutics, Inc. | 186.53M | -12.44% | 77,112 | - |
| 311 | SLGL | Sol-Gel Technologies Ltd. | 182.03M | 0.53% | 10,171 | 18.97M |
| 312 | CBIO | Crescent Biopharma, Inc. | 181.81M | -1.59% | 29,492 | - |
| 313 | MIST | Milestone Pharmaceuticals Inc. | 181.32M | -2.99% | 353,376 | - |
| 314 | KLRS | Kalaris Therapeutics, Inc. | 176.92M | -5.59% | 4,055 | - |
| 315 | TLSA | Tiziana Life Sciences Ltd | 174.84M | -2.84% | 97,092 | - |
| 316 | GALT | Galectin Therapeutics Inc. | 174.08M | -2.17% | 27,148 | - |
| 317 | MOLN | Molecular Partners AG | 173.30M | -0.42% | 133 | 856.30K |
| 318 | SGMT | Sagimet Biosciences Inc. | 170.41M | -7.09% | 211,728 | - |
| 319 | THAR | Tharimmune, Inc. | 168.79M | -8.57% | 297,434 | - |
| 320 | CCCC | C4 Therapeutics, Inc. | 168.63M | -5.43% | 253,228 | 30.11M |
| 321 | EDIT | Editas Medicine, Inc. | 166.44M | -4.21% | 213,631 | 46.38M |
| 322 | PRLD | Prelude Therapeutics Incorporated | 164.79M | -4.76% | 40,283 | 10.50M |
| 323 | TNYA | Tenaya Therapeutics, Inc. | 162.90M | -4.76% | 1,026,767 | - |
| 324 | RNAC | Cartesian Therapeutics, Inc. | 161.22M | -4.17% | 27,951 | 1.09M |
| 325 | CGEN | Compugen Ltd. | 160.88M | -2.27% | 105,779 | 6.90M |
| 326 | ELDN | Eledon Pharmaceuticals, Inc. | 159.50M | -3.83% | 76,923 | - |
| 327 | IPHA | Innate Pharma S.A. | 159.01M | -3.10% | 62,952 | 14.84M |
| 328 | RANI | Rani Therapeutics Holdings, Inc. | 153.12M | -5.97% | 252,858 | 1.20M |
| 329 | ZNTL | Zentalis Pharmaceuticals, Inc. | 151.52M | -2.50% | 76,605 | 26.87M |
| 330 | PRQR | ProQR Therapeutics N.V. | 150.64M | -3.38% | 61,763 | 18.86M |
| 331 | ELTX | Elicio Therapeutics, Inc. | 148.19M | -2.53% | 47,430 | - |
| 332 | ABOS | Acumen Pharmaceuticals, Inc. | 142.35M | -4.86% | 32,458 | - |
| 333 | NKTX | Nkarta, Inc. | 141.35M | -0.50% | 84,474 | - |
| 334 | VXRT | Vaxart, Inc. | 141.30M | -0.19% | 12,109 | 148.20M |
| 335 | CRBU | Caribou Biosciences, Inc. | 140.20M | -4.46% | 311,394 | 9.30M |
| 336 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 138.96M | -5.30% | 25,548 | - |
| 337 | CNTB | Connect Biopharma Holdings Limited | 138.64M | -6.42% | 92,357 | 762.00K |
| 338 | SGMO | Sangamo Therapeutics, Inc. | 137.90M | -4.87% | 597,467 | 32.88M |
| 339 | ADAG | Adagene Inc. | 137.15M | -2.35% | 26,721 | 103.20K |
| 340 | CBUS | Cibus, Inc. | 135.79M | 0.50% | 15,705 | 3.79M |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 132.94M | -1.18% | 4,595 | 2.00M |
| 342 | SPRO | Spero Therapeutics, Inc. | 131.83M | -0.85% | 58,403 | 40.55M |
| 343 | WHWK | Whitehawk Therapeutics, Inc. | 130.07M | -2.13% | 2,559 | 14.38M |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 129.81M | -5.18% | 278,195 | - |
| 345 | ALXO | ALX Oncology Holdings Inc. | 129.04M | -6.67% | 177,007 | - |
| 346 | MCRB | Seres Therapeutics, Inc. | 126.57M | -2.23% | 12,498 | 351.00K |
| 347 | FATE | Fate Therapeutics, Inc. | 126.31M | 0.46% | 273,428 | 7.14M |
| 348 | BDTX | Black Diamond Therapeutics, Inc. | 125.91M | -3.07% | 172,492 | 70.00M |
| 349 | KPTI | Karyopharm Therapeutics Inc. | 118.19M | -2.05% | 73,883 | 142.53M |
| 350 | ACOG | Alpha Cognition Inc. | 116.54M | -0.19% | 44,591 | 7.43M |
| 351 | MENS | Jyong Biotech Ltd. | 113.81M | -8.64% | 125,304 | - |
| 352 | COYA | Coya Therapeutics, Inc. | 113.72M | -2.22% | 52,591 | 3.99M |
| 353 | KRRO | Korro Bio, Inc. | 111.97M | -2.06% | 33,228 | 7.37M |
| 354 | INO | Inovio Pharmaceuticals, Inc. | 110.61M | -4.73% | 445,538 | 182.34K |
| 355 | MGNX | MacroGenics, Inc. | 109.44M | 1.17% | 123,804 | 127.63M |
| 356 | CDXS | Codexis, Inc. | 108.39M | -4.00% | 251,408 | 52.93M |
| 357 | FBIO | Fortress Biotech, Inc. | 108.32M | -6.93% | 212,518 | 62.30M |
| 358 | GNLX | Genelux Corporation | 107.61M | 0.41% | 46,453 | 8.00K |
| 359 | TTRX | Turn Therapeutics Inc. | 107.48M | -1.88% | 556 | - |
| 360 | SEER | Seer, Inc. | 105.75M | 6.21% | 520,365 | 16.38M |
| 361 | CRDF | Cardiff Oncology, Inc. | 104.75M | 0.32% | 105,550 | 501.00K |
| 362 | SAVA | Cassava Sciences, Inc. | 101.45M | -3.67% | 81,333 | - |
| 363 | AGEN | Agenus Inc. | 99.71M | -4.50% | 226,762 | 106.83M |
| 364 | ACTU | Actuate Therapeutics, Inc. | 99.25M | - | 1,092 | - |
| 365 | DWTX | Dogwood Therapeutics, Inc. | 97.21M | 0.33% | 1,632 | - |
| 366 | VANI | Vivani Medical, Inc. | 95.83M | -4.76% | 184,106 | - |
| 367 | CGTX | Cognition Therapeutics, Inc. | 95.78M | -4.82% | 248,760 | - |
| 368 | VRCA | Verrica Pharmaceuticals Inc. | 93.86M | -2.65% | 46,490 | 30.83M |
| 369 | ANIX | Anixa Biosciences, Inc. | 93.59M | -5.60% | 39,685 | - |
| 370 | EQ | Equillium, Inc. | 92.56M | - | 125,721 | 4.39M |
| 371 | SPRB | Spruce Biosciences, Inc. | 90.86M | 1.51% | 6,145 | 697.00K |
| 372 | DTIL | Precision BioSciences, Inc. | 90.75M | 0.27% | 784,625 | 698.00K |
| 373 | ARTV | Artiva Biotherapeutics, Inc. | 90.57M | -5.14% | 42,153 | 251.00K |
| 374 | BMEA | Biomea Fusion, Inc. | 90.50M | -5.19% | 288,819 | - |
| 375 | NBY | NovaBay Pharmaceuticals, Inc. | 89.43M | -1.44% | 274,493 | 10.30M |
| 376 | EXOZ | eXoZymes, Inc. | 87.36M | 0.29% | 805 | -700.00 |
| 377 | CSBR | Champions Oncology, Inc. | 87.07M | 2.45% | 385 | 58.42M |
| 378 | IMUX | Immunic, Inc. | 86.48M | -9.53% | 1,726,098 | - |
| 379 | ONCY | Oncolytics Biotech Inc. | 86.10M | -5.00% | 610,080 | - |
| 380 | ATYR | aTyr Pharma, Inc. | 82.92M | -3.84% | 182,403 | 190.00K |
| 381 | PYXS | Pyxis Oncology, Inc. | 81.25M | -6.12% | 161,254 | 2.82M |
| 382 | MNOV | MediciNova, Inc. | 80.60M | 0.61% | 5,372 | 257.92K |
| 383 | OKYO | OKYO Pharma Limited | 79.89M | -5.74% | 135,925 | - |
| 384 | IMA | ImageneBio, Inc. | 77.96M | 0.41% | 842 | 800.00K |
| 385 | PYPD | PolyPid Ltd. | 75.02M | -3.63% | 11,610 | - |
| 386 | HURA | TuHURA Biosciences, Inc. | 73.47M | -6.92% | 4,611,113 | - |
| 387 | XBIT | XBiotech Inc. | 73.17M | -0.83% | 739 | - |
| 388 | IBIO | iBio, Inc. | 70.29M | -4.85% | 349,624 | 300.00K |
| 389 | COEP | Coeptis Therapeutics Holdings, Inc. | 70.26M | 1.56% | 8,857 | 501.00K |
| 390 | ENTX | Entera Bio Ltd. | 70.16M | 5.52% | 184,342 | 124.00K |
| 391 | PLRX | Pliant Therapeutics, Inc. | 70.05M | -1.72% | 127,451 | - |
| 392 | PTHS | Pelthos Therapeutics Inc. | 69.90M | 0.62% | 684 | 7.41M |
| 393 | ACET | Adicet Bio, Inc. | 69.33M | -3.79% | 64,678 | - |
| 394 | ATHE | Alterity Therapeutics Limited | 69.21M | 2.01% | 3,069 | 3.57M |
| 395 | HYFT | MindWalk Holdings Corp. | 69.10M | -4.52% | 104,853 | 19.02M |
| 396 | MAIA | MAIA Biotechnology, Inc. | 67.35M | -5.88% | 195,937 | - |
| 397 | GANX | Gain Therapeutics, Inc. | 66.54M | -2.81% | 126,913 | - |
| 398 | GUTS | Fractyl Health, Inc. | 63.65M | -6.78% | 1,184,934 | 3.00K |
| 399 | ANVS | Annovis Bio, Inc. | 62.28M | -2.08% | 65,806 | - |
| 400 | BYSI | BeyondSpring Inc. | 61.27M | - | 17,541 | 1.88M |
| 401 | MREO | Mereo BioPharma Group plc | 61.04M | -6.44% | 833,543 | 500.00K |
| 402 | PMVP | PMV Pharmaceuticals, Inc. | 59.06M | -5.13% | 27,190 | - |
| 403 | ICCC | ImmuCell Corporation | 58.80M | -1.96% | 8,610 | 27.77M |
| 404 | ETHZ | ETHZilla Corporation | 58.75M | -3.13% | 130,120 | 4.11M |
| 405 | RADX | Radiopharm Theranostics Limited | 57.64M | -0.79% | 3,918 | 8.20M |
| 406 | KZIA | Kazia Therapeutics Limited | 56.77M | -4.58% | 28,618 | 1.20M |
| 407 | IFRX | InflaRx N.V. | 56.18M | -1.85% | 91,376 | 73.73K |
| 408 | MGX | Metagenomi Therapeutics, Inc. | 56.13M | -4.78% | 19,964 | 30.91M |
| 409 | GRCE | Grace Therapeutics, Inc. | 55.63M | -2.04% | 7,476 | - |
| 410 | ESLA | Estrella Immunopharma, Inc. | 54.64M | -5.80% | 56,021 | - |
| 411 | TCRX | TScan Therapeutics, Inc. | 53.91M | -4.67% | 82,064 | 8.42M |
| 412 | NRXP | NRx Pharmaceuticals, Inc. | 53.88M | -3.19% | 80,859 | 242.00K |
| 413 | INKT | MiNK Therapeutics, Inc. | 53.43M | 1.71% | 1,070 | - |
| 414 | NTRB | Nutriband Inc. | 53.00M | - | 2,282 | 2.28M |
| 415 | TIL | Instil Bio, Inc. | 52.70M | 1.04% | 3,746 | - |
| 416 | CING | Cingulate Inc. | 50.89M | -1.10% | 136,829 | - |
| 417 | IBO | Impact BioMedical Inc. | 49.34M | 3.29% | 13,453 | 25.00K |
| 418 | NRXS | NeurAxis, Inc. | 48.31M | -1.84% | 5,580 | 3.36M |
| 419 | LPCN | Lipocine Inc. | 47.30M | -3.29% | 9,991 | 4.32M |
| 420 | QNCX | Quince Therapeutics, Inc. | 47.05M | 60.11% | 270,788,736 | - |
| 421 | ACRV | Acrivon Therapeutics, Inc. | 46.86M | -4.81% | 362,956 | - |
| 422 | TVGN | Tevogen Bio Holdings Inc. | 46.69M | -7.47% | 265,854 | - |
| 423 | QTTB | Q32 Bio Inc. | 46.39M | -2.33% | 22,982 | - |
| 424 | KZR | Kezar Life Sciences, Inc. | 45.59M | 0.08% | 1,122 | - |
| 425 | ALGS | Aligos Therapeutics, Inc. | 45.47M | 2.92% | 36,268 | 2.65M |
| 426 | CRVO | CervoMed Inc. | 45.06M | -4.51% | 6,404 | 6.16M |
| 427 | PSTV | Plus Therapeutics, Inc. | 44.63M | -4.10% | 1,414,914 | 5.26M |
| 428 | LONA | LeonaBio, Inc. | 42.69M | -6.68% | 5,193 | - |
| 429 | NXTC | NextCure, Inc. | 41.98M | -2.24% | 81,347 | - |
| 430 | OSTX | OS Therapies Incorporated | 41.91M | -5.56% | 253,131 | - |
| 431 | INMB | INmune Bio Inc. | 40.94M | -3.75% | 52,480 | 50.00K |
| 432 | CVM | CEL-SCI Corporation | 40.87M | -2.99% | 8,571 | - |
| 433 | ABVC | ABVC BioPharma, Inc. | 40.74M | -2.94% | 24,401 | 797.92K |
| 434 | APLM | Apollomics, Inc. | 40.45M | 1.07% | 491 | 6.93M |
| 435 | TELO | Telomir Pharmaceuticals, Inc. | 40.23M | - | 71,107 | - |
| 436 | LSTA | Lisata Therapeutics, Inc. | 39.87M | -0.44% | 18,661 | 1.07M |
| 437 | VERU | Veru Inc. | 38.28M | 3.25% | 55,676 | 16.89M |
| 438 | PDSB | PDS Biotechnology Corporation | 37.77M | -3.25% | 123,252 | - |
| 439 | LITS | Lite Strategy, Inc. | 37.69M | -0.49% | 130,306 | - |
| 440 | PLUR | Pluri Inc. | 37.67M | -0.66% | 1,829 | 1.33M |
| 441 | ATOS | Atossa Therapeutics, Inc. | 37.46M | -9.75% | 130,697 | - |
| 442 | RNXT | RenovoRx, Inc. | 36.21M | -0.20% | 12,280 | 928.00K |
| 443 | JSPR | Jasper Therapeutics, Inc. | 35.54M | -3.05% | 146,008 | - |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 35.25M | -0.88% | 27,605 | 90.00K |
| 445 | CELU | Celularity Inc. | 35.04M | -4.33% | 20,215 | 40.58M |
| 446 | XLO | Xilio Therapeutics, Inc. | 34.70M | -5.12% | 161,279 | 31.80M |
| 447 | TVRD | Tvardi Therapeutics, Inc. | 34.19M | -3.57% | 7,826 | - |
| 448 | OKUR | OnKure Therapeutics, Inc. | 34.01M | - | 258 | - |
| 449 | NRSN | NeuroSense Therapeutics Ltd. | 33.41M | -1.09% | 54,153 | - |
| 450 | ATRA | Atara Biotherapeutics, Inc. | 33.24M | -4.55% | 35,875 | 151.93M |
| 451 | HOWL | Werewolf Therapeutics, Inc. | 32.85M | -5.71% | 49,715 | 1.14M |
| 452 | LTRN | Lantern Pharma Inc. | 32.66M | 0.35% | 4,932 | - |
| 453 | GLTO | Galecto, Inc. | 32.25M | -6.18% | 1,461,943 | - |
| 454 | OTLK | Outlook Therapeutics, Inc. | 32.01M | 3.44% | 1,092,881 | 1.41M |
| 455 | KYNB | Kyntra Bio, Inc. | 31.92M | 1.41% | 23,418 | 8.30M |
| 456 | HYPD | Hyperion DeFi, Inc. | 31.41M | 1.08% | 42,642 | 345.32K |
| 457 | PMN | ProMIS Neurosciences, Inc. | 30.84M | 0.26% | 11,838 | - |
| 458 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 30.77M | -0.49% | 1,575,550 | - |
| 459 | RNTX | Rein Therapeutics Inc. | 30.24M | 0.92% | 11,337 | - |
| 460 | TPST | Tempest Therapeutics, Inc. | 30.15M | -7.57% | 62,088 | - |
| 461 | ANTX | AN2 Therapeutics, Inc. | 30.14M | - | 114 | - |
| 462 | CUE | Cue Biopharma, Inc. | 29.65M | -3.68% | 135,074 | 7.10M |
| 463 | DYAI | Dyadic International, Inc. | 29.44M | -2.33% | 5,884 | 3.34M |
| 464 | PASG | Passage Bio, Inc. | 29.36M | -0.91% | 24,290 | - |
| 465 | BRNS | Barinthus Biotherapeutics plc | 28.99M | - | 346 | 14.97M |
| 466 | EVAX | Evaxion A/S | 28.02M | -1.18% | 7,331 | 7.65M |
| 467 | XCUR | Exicure, Inc. | 27.89M | 1.51% | 4,130 | 500.00K |
| 468 | PTN | Palatin Technologies, Inc. | 27.24M | 0.18% | 1,714 | 8.85M |
| 469 | BCTX | BriaCell Therapeutics Corp. | 26.34M | -4.25% | 164,731 | - |
| 470 | AEON | AEON Biopharma, Inc. | 26.32M | -0.95% | 4,946 | - |
| 471 | IOBT | IO Biotech, Inc. | 25.90M | -1.93% | 1,525,987 | - |
| 472 | BOLD | Boundless Bio, Inc. | 25.18M | 0.45% | 18,890 | - |
| 473 | IGC | IGC Pharma, Inc. | 24.91M | -1.14% | 110,843 | 1.11M |
| 474 | RLYB | Rallybio Corporation | 24.82M | -2.08% | 734 | 674.00K |
| 475 | DARE | Daré Bioscience, Inc. | 24.29M | 0.59% | 11,797 | -57.13K |
| 476 | MRKR | Marker Therapeutics, Inc. | 23.51M | -9.03% | 140,495 | 4.69M |
| 477 | SNTI | Senti Biosciences, Inc. | 23.16M | -0.17% | 69,631 | - |
| 478 | INTS | Intensity Therapeutics, Inc. | 22.64M | 0.64% | 46,494 | - |
| 479 | SKYE | Skye Bioscience, Inc. | 22.43M | -2.85% | 106,513 | - |
| 480 | PLRZ | Polyrizon Ltd. | 22.32M | 1.67% | 9,249 | - |
| 481 | LIXT | Lixte Biotechnology Holdings, Inc. | 22.30M | -4.83% | 16,815 | - |
| 482 | VTGN | Vistagen Therapeutics, Inc. | 21.81M | -2.23% | 191,139 | 721.00K |
| 483 | LIMN | Liminatus Pharma, Inc. | 21.65M | -36.52% | 5,855,433 | - |
| 484 | NEUP | Neuphoria Therapeutics Inc. | 21.40M | -1.73% | 7,215 | 15.65M |
| 485 | GNTA | Genenta Science S.p.A. | 21.09M | -2.17% | 57,589 | - |
| 486 | LNAI | Lunai Bioworks Inc. | 20.85M | -16.04% | 191,810 | - |
| 487 | NNVC | NanoViricides, Inc. | 20.85M | -4.31% | 80,062 | - |
| 488 | JUNS | Jupiter Neurosciences, Inc. | 20.21M | -4.51% | 4,393 | - |
| 489 | SER | Serina Therapeutics, Inc. | 19.85M | -12.38% | 119,340 | 116.00K |
| 490 | ANEB | Anebulo Pharmaceuticals, Inc. | 19.32M | -1.22% | 2,528 | - |
| 491 | INAB | IN8bio, Inc. | 18.46M | -1.05% | 7,280 | - |
| 492 | VYNE | VYNE Therapeutics Inc. | 18.40M | -0.77% | 117,635 | 524.00K |
| 493 | KLTO | Klotho Neurosciences, Inc. | 17.30M | 0.94% | 101,206 | - |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 17.03M | 1.05% | 424,661 | - |
| 495 | FBLG | FibroBiologics, Inc. | 17.01M | -4.30% | 193,823 | - |
| 496 | LEXX | Lexaria Bioscience Corp. | 16.96M | -0.03% | 9,823 | 522.00K |
| 497 | KTTA | Pasithea Therapeutics Corp. | 16.93M | -1.98% | 6,520 | - |
| 498 | CASI | CASI Pharmaceuticals, Inc. | 16.85M | 1.21% | 803 | 26.85M |
| 499 | ITRM | Iterum Therapeutics plc | 16.23M | 0.07% | 94,957 | 390.00K |
| 500 | QNTM | Quantum BioPharma Ltd. | 15.30M | -0.76% | 11,473 | - |
| 501 | TRAW | Traws Pharma, Inc. | 15.26M | -1.04% | 16,110 | 2.85M |
| 502 | ALLR | Allarity Therapeutics, Inc. | 14.70M | -1.75% | 30,771 | - |
| 503 | CLRB | Cellectar Biosciences, Inc. | 14.08M | -0.60% | 5,502 | - |
| 504 | HOTH | Hoth Therapeutics, Inc. | 13.91M | -5.62% | 171,870 | - |
| 505 | PHIO | Phio Pharmaceuticals Corp. | 13.67M | 13.39% | 9,889,838 | - |
| 506 | CVKD | Cadrenal Therapeutics, Inc. | 13.56M | -0.17% | 873 | - |
| 507 | BLRX | BioLineRx Ltd. | 13.54M | -2.17% | 2,126 | 12.74M |
| 508 | NCEL | NewcelX Ltd. | 13.45M | 2.08% | 3,878 | - |
| 509 | KAPA | Kairos Pharma, Ltd. | 13.40M | 0.39% | 9,441 | - |
| 510 | COCP | Cocrystal Pharma, Inc. | 13.16M | -0.28% | 15,649 | - |
| 511 | BCDA | BioCardia, Inc. | 12.95M | -2.40% | 30,804 | 3.00K |
| 512 | GTBP | GT Biopharma, Inc. | 12.79M | -6.85% | 228,722 | - |
| 513 | OSRH | OSR Holdings, Inc. | 12.61M | -4.64% | 107,778 | -90.52K |
| 514 | BCAB | BioAtla, Inc. | 12.55M | -2.34% | 268,250 | 11.00M |
| 515 | CRIS | Curis, Inc. | 12.54M | -3.00% | 24,032 | 11.65M |
| 516 | MBRX | Moleculin Biotech, Inc. | 12.42M | -2.54% | 7,895 | - |
| 517 | GDTC | CytoMed Therapeutics Limited | 12.12M | -1.88% | 70,550 | 573.19K |
| 518 | IMNN | Imunon, Inc. | 11.73M | -0.29% | 9,732 | - |
| 519 | LGVN | Longeveron Inc. | 11.72M | -0.99% | 62,092 | 1.44M |
| 520 | AKTX | Akari Therapeutics, Plc | 11.47M | 4.67% | 54,189 | - |
| 521 | SNSE | Sensei Biotherapeutics, Inc. | 11.35M | 2.04% | 1,120 | - |
| 522 | KALA | KALA BIO, Inc. | 11.00M | -8.96% | 360,913 | - |
| 523 | SNGX | Soligenix, Inc. | 10.89M | -3.57% | 126,357 | 2.34K |
| 524 | CALC | CalciMedica, Inc. | 10.42M | -1.87% | 133,635 | - |
| 525 | EVGN | Evogene Ltd. | 9.86M | - | 369,097 | 8.02M |
| 526 | BOLT | Bolt Biotherapeutics, Inc. | 9.79M | 0.39% | 16,670 | 5.20M |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 9.60M | - | 6,448 | - |
| 528 | CLGN | CollPlant Biotechnologies Ltd. | 9.43M | -6.84% | 22,021 | 2.48M |
| 529 | RNAZ | TransCode Therapeutics, Inc. | 9.42M | -2.38% | 4,765 | - |
| 530 | NCNA | NuCana plc | 9.26M | -0.22% | 9,437 | - |
| 531 | EDSA | Edesa Biotech, Inc. | 9.00M | 2.86% | 11,043 | - |
| 532 | PHGE | BiomX Inc. | 8.96M | -14.07% | 124,310 | - |
| 533 | PULM | Pulmatrix, Inc. | 8.69M | -2.86% | 2,615 | 3.00K |
| 534 | XTLB | XTL Biopharmaceuticals Ltd. | 8.59M | - | 17,854 | 968.00K |
| 535 | GRDX | GridAI Technologies Corp. | 8.57M | -5.90% | 37,768 | - |
| 536 | ICU | SeaStar Medical Holding Corporation | 8.51M | - | 6,623 | 881.00K |
| 537 | BIVI | BioVie Inc. | 8.26M | -7.95% | 23,619 | - |
| 538 | ADXN | Addex Therapeutics Ltd | 7.97M | 1.81% | 1,044 | 198.82K |
| 539 | KPRX | Kiora Pharmaceuticals, Inc. | 7.89M | -4.44% | 17,177 | 20.00K |
| 540 | PMCB | PharmaCyte Biotech, Inc. | 7.31M | -7.76% | 41,573 | - |
| 541 | IMRN | Immuron Limited | 7.14M | -1.80% | 7,189 | 4.78M |
| 542 | TOVX | Theriva Biologics, Inc. | 7.07M | 2.16% | 597,776 | - |
| 543 | REVB | Revelation Biosciences, Inc. | 7.03M | -3.90% | 51,386 | - |
| 544 | APVO | Aptevo Therapeutics Inc. | 6.83M | -2.01% | 2,938 | - |
| 545 | CELZ | Creative Medical Technology Holdings, Inc. | 6.64M | -1.55% | 19,530 | 6.00K |
| 546 | PPBT | Purple Biotech Ltd | 6.63M | 1.66% | 25,377 | - |
| 547 | ALZN | Alzamend Neuro, Inc. | 6.61M | -9.37% | 72,322 | - |
| 548 | APM | Aptorum Group Limited | 6.52M | -4.66% | 4,831 | - |
| 549 | QNRX | Quoin Pharmaceuticals, Ltd. | 6.41M | 1.87% | 627 | - |
| 550 | CLDI | Calidi Biotherapeutics, Inc. | 6.37M | 4.89% | 6,230 | - |
| 551 | TCRT | Alaunos Therapeutics, Inc. | 6.23M | 2.57% | 774 | 6.00K |
| 552 | MBIO | Mustang Bio, Inc. | 6.07M | -2.61% | 7,781 | - |
| 553 | CANF | Can-Fite BioPharma Ltd. | 5.69M | 0.23% | 2,922 | 560.00K |
| 554 | MTVA | MetaVia Inc. | 5.62M | 3.09% | 31,283 | - |
| 555 | PCSA | Processa Pharmaceuticals, Inc. | 5.26M | -0.32% | 7,930 | - |
| 556 | SLXN | Silexion Therapeutics Corp | 5.22M | 1.21% | 16,237 | - |
| 557 | BGMS | Bio Green Med Solution, Inc. | 4.97M | -0.49% | 2,328 | 81.00K |
| 558 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.97M | -4.70% | 3,000 | 1.36M |
| 559 | VIVS | VivoSim Labs, Inc. | 4.82M | -3.65% | 52,749 | 140.00K |
| 560 | XBIO | Xenetic Biosciences, Inc. | 4.81M | -1.41% | 4,871 | 2.86M |
| 561 | GNPX | Genprex, Inc. | 4.78M | -4.63% | 54,822 | - |
| 562 | ACXP | Acurx Pharmaceuticals, Inc. | 4.60M | -4.85% | 16,629 | - |
| 563 | DCOY | Decoy Therapeutics Inc. | 4.53M | -5.09% | 80,094 | - |
| 564 | APRE | Aprea Therapeutics, Inc. | 4.46M | -0.47% | 19,560 | 488.24K |
| 565 | GOVX | GeoVax Labs, Inc. | 4.31M | -7.38% | 21,452 | 3.35M |
| 566 | CYCN | Cyclerion Therapeutics, Inc. | 4.27M | -4.21% | 17,462 | 2.86M |
| 567 | BRTX | BioRestorative Therapies, Inc. | 4.17M | -26.42% | 862,387 | 383.40K |
| 568 | SILO | Silo Pharma, Inc. | 4.07M | 3.67% | 50,692 | 72.10K |
| 569 | MTNB | Matinas BioPharma Holdings, Inc. | 3.97M | -1.39% | 1,034 | - |
| 570 | DRMA | Dermata Therapeutics, Inc. | 3.94M | -2.37% | 36,380 | - |
| 571 | INDP | Indaptus Therapeutics, Inc. | 3.88M | -4.42% | 5,859 | - |
| 572 | MLEC | Moolec Science SA | 3.88M | 6.59% | 9,463 | 7.83M |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 3.76M | 2.39% | 14,766 | - |
| 574 | ADIL | Adial Pharmaceuticals, Inc. | 3.48M | 3.30% | 38,196 | - |
| 575 | ASBP | Aspire Biopharma Holdings, Inc. | 3.47M | -8.51% | 8,810,763 | 1.94K |
| 576 | GRI | GRI Bio, Inc. | 3.40M | -1.67% | 30,642 | - |
| 577 | ABP | Abpro Holdings, Inc. | 3.40M | -25.15% | 1,547,707 | 183.00K |
| 578 | SPRC | SciSparc Ltd. | 3.21M | -4.67% | 14,438 | 1.31M |
| 579 | PBM | Psyence Biomedical Ltd. | 3.08M | -5.35% | 35,323 | - |
| 580 | XRTX | XORTX Therapeutics Inc. | 2.98M | -1.05% | 22,816 | - |
| 581 | OGEN | Oragenics, Inc. | 2.92M | -4.67% | 10,739 | - |
| 582 | ARTL | Artelo Biosciences, Inc. | 2.89M | -0.73% | 2,426 | - |
| 583 | ENVB | Enveric Biosciences, Inc. | 2.86M | -4.19% | 9,874 | - |
| 584 | JAGX | Jaguar Health, Inc. | 2.79M | -4.36% | 51,348 | 11.79M |
| 585 | SCNI | Scinai Immunotherapeutics Ltd. | 2.77M | 0.10% | 3,931 | 1.15M |
| 586 | HCWB | HCW Biologics Inc. | 2.70M | -0.99% | 10,349 | 422.03K |
| 587 | PPCB | Propanc Biopharma, Inc. | 2.63M | 2.61% | 192,088 | - |
| 588 | CNSP | CNS Pharmaceuticals, Inc. | 2.54M | - | 4,345 | - |
| 589 | LYRA | Lyra Therapeutics, Inc. | 2.52M | -3.40% | 5,662 | 600.00K |
| 590 | CDT | CDT Equity Inc. | 2.45M | -4.91% | 23,681 | - |
| 591 | BBLG | Bone Biologics Corporation | 2.44M | - | 3,787 | - |
| 592 | ERNA | Ernexa Therapeutics Inc. | 2.43M | 1.64% | 237,001 | 1,000.00 |
| 593 | CDIO | Cardio Diagnostics Holdings, Inc. | 2.41M | -3.64% | 41,924 | 15.78K |
| 594 | ELAB | PMGC Holdings Inc. | 2.32M | 14.62% | 25,133,715 | 285.95K |
| 595 | ONCO | Onconetix, Inc. | 2.25M | -4.30% | 20,505 | 1.22M |
| 596 | AZTR | Azitra, Inc. | 2.16M | -0.10% | 363,064 | 7.50K |
| 597 | CMND | Clearmind Medicine Inc. | 1.75M | -1.68% | 33,981 | - |
| 598 | VRAX | Virax Biolabs Group Limited | 1.72M | -0.22% | 49,956 | 2.99K |
| 599 | ENSC | Ensysce Biosciences, Inc. | 1.42M | -11.14% | 443,224 | 4.49M |
| 600 | ADTX | Aditxt, Inc. | 1.21M | -0.57% | 39,920 | 5.95K |
| 601 | BDRX | Biodexa Pharmaceuticals Plc | 1.03M | -3.15% | 23,119 | 104.90K |